A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis

Part of paid clinical trials in Los Angeles, California.

Sponsor
Cedars-Sinai Medical Center
Study ID
NCT05664880
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Paricalcitol — DRUG
    2 MCG Oral Capsule
  • Placebo — DRUG
    Matching capsule to 2 MCG Paricalcitol Oral Capsule

Study Details

The purpose of this pilot study to examine the feasibility and acceptability of paricalcitol in adults with Chronic Pancreatitis (CP).

Key Dates

Start date
Jun 1, 2023
Status verified
Nov 2025
Primary completion
Jun 1, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
24 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Paricalcitol
    Participants receive Paricalcitol 2mcg capsule once daily for 12 months.
  • Placebo Comparator: Placebo
    Participants receive Paricalcitol Placebo capsule matching Paricalcitol once daily for 12 months.

Primary Outcome Measure

Examine the feasibility of testing the effect of paricalcitol on health-related quality of life in patients with chronic pancreatitis [ Time Frame: End of study (12 Months) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Arax Shanlian
[email protected]
3109671110
Stephen Pandol, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Medical Center· Los Angeles, CA

Related Studies